Koers Zalicus Inc Nasdaq
Aandelen
US98887C2044
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
2016 | Transcript : EPIRUS Biopharmaceuticals, Inc., Q4 2015 Earnings Call, Mar 15, 2016 | |
2015 | Transcript : EPIRUS Biopharmaceuticals, Inc., Q3 2015 Earnings Call, Nov 16, 2015 |
Omzet 2014 | 0 0 | Omzet 2015 | 0,7 0,65 | Marktkapitalisatie | 75,33 mln. 69,35 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2014 | -41 mln. -37,74 mln. | Nettowinst (verlies) 2015 | -52 mln. -47,87 mln. | EV/omzet 2014 | 14.770.294.750 x |
Nettoliquiditeiten 2014 | 14,18 mln. 13,05 mln. | Nettoliquiditeiten 2015 | 16,68 mln. 15,36 mln. | EV/omzet 2015 | 83.658.631 x |
K/w-verhouding 2014 |
-0,83
x | K/w-verhouding 2015 |
-1,35
x | Werknemers | - |
Dividendrendement 2014 * |
-
| Dividendrendement 2015 |
-
| Vrij verhandelbaar | 100% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+52,74% | 55,7 mld. | |
+41,08% | 39,91 mld. | |
-5,56% | 39,57 mld. | |
-5,56% | 28,16 mld. | |
+16,49% | 26,3 mld. | |
-19,97% | 18,94 mld. | |
+32,69% | 12,17 mld. | |
+26,68% | 12,12 mld. | |
+2,46% | 12,12 mld. |
- Beurs
- Aandelen
- Koers EPRSQ
- Koers